Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories [0.03%]
25个国家和地区的乙肝病毒校正患病率估算结果
Polaris Observatory Collaborators
Polaris Observatory Collaborators
Background & aims: Hepatitis delta virus (HDV) is a satellite RNA virus that requires the hepatitis B virus (HBV) for assembly and propagation. Individuals infected with HDV progress to advanced liver disease faster than ...
Detour of bile acid routes as therapeutic roadmap for cholemic nephropathy [0.03%]
胆汁酸途径的分流作为胆汁性肾病的治疗路线图
Peter Fickert
Peter Fickert
Jimmy Che-To Lai,Vincent Wai-Sun Wong
Jimmy Che-To Lai
Alberto Zanetto,Marco Senzolo,Filippo Pelizzaro et al.
Alberto Zanetto et al.
E. coli´s fight against TYROnny: Designing a bacterial strain to tackle tyrosinemia type 1 [0.03%]
大肠杆菌对抗TYROnny：设计一种细菌菌株以应对酪氨酸血症1型
Jöran Lücke,Samuel Huber
Jöran Lücke
Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes [0.03%]
酒精公共卫生政策与全球癌症、肝病和心血管疾病结局之间的关系
Luis Antonio Díaz,Eduardo Fuentes-López,Francisco Idalsoaga et al.
Luis Antonio Díaz et al.
Background & aims: The long-term impact of alcohol-related public health policies (PHPs) on disease burden is unclear. We aimed to assess the association between alcohol-related PHPs and alcohol-related health consequence...
Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis progression and resolution in mice [0.03%]
红氧化还原敏感高迁移率族盒蛋白1同种型参与小鼠肝纤维化的发展和消退
Xiaodong Ge,Romain Desert,Fernando Magdaleno et al.
Xiaodong Ge et al.
Background & aims: High-mobility group box-1 (HMGB1) significantly increases and undergoes post-translational modifications (PTMs) in response to liver injury. Since oxidative stress plays a major role in liver fibrosis a...
Ashwin Balagopal,David L Thomas
Ashwin Balagopal
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease [0.03%]
全球非酒精性脂肪肝病医患耻感调查
Zobair M Younossi,Saleh A Alqahtani,Khalid Alswat et al.
Zobair M Younossi et al.
Background & aims: Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this cross-sectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disea...